IDEXX Laboratories, Inc. (IDXX) Q4 2023 Earnings Call Transcript
IDEXX Laboratories, Inc. (IDXX) Q4 2023 Earnings Call Transcript
IDEXX (IDXX) Q4 Earnings Surpass Estimates, Margins Fall
Across testing modalities, IDEXX (IDXX) achieves strong global growth in the fourth quarter.
Idexx (IDXX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Idexx (IDXX) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compa...
Idexx Laboratories (IDXX) Q4 Earnings and Revenues Top Estimates
Idexx Laboratories (IDXX) came out with quarterly earnings of $2.32 per share, beating the Zacks Consensus Estimate of $2.12 per share. This compares to earnings of $2.05 per share a year ago.
Should You Buy IDEXX Laboratories (IDXX) Ahead of Earnings?
IDEXX Laboratories (IDXX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
IQV or IDXX: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Instruments sector have probably already heard of IQVIA Holdings (IQV) and Idexx Laboratories (IDXX). But which of these two companies is the best ...
Unveiling Idexx (IDXX) Q4 Outlook: Wall Street Estimates for Key Metrics
Evaluate the expected performance of Idexx (IDXX) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metric...
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Why Idexx (IDXX) is Poised to Beat Earnings Estimates Again
Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
IDEXX Laboratories (IDXX) to Post Q4 Earnings: What's in Store?
Strength in CAG Diagnostics and Water businesses are likely to have boosted IDEXX Laboratories' (IDXX) revenues in Q4.
IDEXX (IDXX) Enhances Fecal Dx Antigen Testing Platform
IDEXX's (IDXX) Fecal Dx antigen testing detects the most prevalent and clinically relevant intestinal parasites in dogs and cats.
IDEXX's (IDXX) Upcoming Launch to Detect Canine Leishmaniosis
IDEXX (IDXX) expands the SNAP franchise with a comprehensive solution for detecting canine leishmaniosis.
Compared to Estimates, Idexx (IDXX) Q3 Earnings: A Look at Key Metrics
Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall St...
IDEXX Laboratories (IDXX) to Post Q3 Earnings: What's in Store?
IDEXX Laboratories' (IDXX) third-quarter 2023 results are expected to reflect an impressive performance of the CAG segment.
Here's Why You Should Hold on to IDEXX (IDXX) Stock Right Now
Investors are optimistic about IDEXX (IDXX) on solid premium instrument placements and upbeat guidance.
Related Companies